List of Articles of Helicobacter Pylori Group

1.Mohammadi M, Attaran B, Malekzadeh R, Graham DY

Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.

Dig Dis Sci. 2017 Aug;62(8):1890-1896

2.Fakheri H, Bari Z, Aarabi M, Malekzadeh R

Helicobacter pylori eradication in West Asia: a review.

World J Gastroenterol .2014 Aug 14;20(30):10355-67

3.Riahizadeh S, Malekzadeh R, Agah S, Zendehdel N, Sotoudehmanesh R, Ebrahimi-Dariani N, Pourshams A, Vahedi H, Mikaeli J, Khatibian M, Massarrat

Sequential metronidazole-furazolidone or clarithromycin-furazolidone compared to clarithromycin-based quadruple regimens for the eradication of Helicobacter pylori in peptic ulcer disease: a double-blind randomized controlled trial.

Helicobacter. 2010 Dec;15(6):497-504

4 .Mohammadi M, Talebkhan Y, Khalili G, Mahboudi F, Massarrat S, Zamaninia L, Oghalaei A

Advantage of using a home-made ELISA kit for detection of Helicobacter pylori infection over commercially imported kits.

Indian J Med Microbiol. 2008 Apr-Jun;26(2):127-31.

5. Foroumadi A, Rineh A, Emami S, Siavoshi F, Massarrat S, Safari F, Rajabalian S, Falahati M, Lotfali E, Shafiee A

Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3315-20. doi: 10.1016/j.bmcl.2008.04.033. Epub 2008 Apr 15

6.Latifi-Navid S, Siavoshi F, Safari F, Malekzadeh R, Massarrat S

Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pyloriisolates from Iranian dyspeptic patients.

J Antimicrob Chemother. 2007 Jan;59(1):160-1. Epub 2006 Nov 3. No abstract available

7. Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, Khosravi F, Massarrat S

 Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.

Clin Gastroenterol Hepatol. 2008 Feb;6(2):174-9. doi: 10.1016/j.cgh.2007.11.016

8.Latifi-Navid S, Siavoshi F, Safari F, Malekzadeh R, Massarrat S

Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pyloriisolates from Iranian dyspeptic patients.

J Antimicrob Chemother. 2007 Jan;59(1):160-1. Epub 2006 Nov 3. No abstract available

9. Khatibian M, Ajvadi Y, Nasseri-Moghaddam S, Ebrahimi-Dariani N, Vahedi H, Zendehdel N, Sotoudehmanesh R, Agah S, Mikaeli J, Pourshams A, Ali-Asgari A, Malekzadeh R, Massarrat S

Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.

Arch Iran Med. 2007 Apr;10(2):161-7

10.Latifi-Navid S, Siavoshi F, Safari F, Malekzadeh R, Massarrat S

Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pyloriisolates from Iranian dyspeptic patients.

J Antimicrob Chemother. 2007 Jan;59(1):160-1. Epub 2006 Nov 3. No abstract available

11. Safaralizadeh R, Siavoshi F, Malekzadeh R, Akbari MR, Derakhshan MH, Sohrabi MR, Massarrat S

Antimicrobial effectiveness of furazolidone against metronidazole-resistant strains of Helicobacter pylori.

East Mediterr Health J. 2006 May-Jul;12(3-4):286-93

12. Alizadeh-Naeeni M, Saberi-Firoozi M, Pourkhajeh A, Taheri H, Malekzadeh R, Derakhshan MH, Massarrat S

Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study.

 Digestion. 2002;66(2):92-8

I ndian J Gastroenterol. 2005 Mar-Apr;24(2):59-61

13. Zendehdel N, Nasseri-Moghaddam S, Malekzadeh R, Massarrat S, Sotoudeh M, Siavoshi F

Helicobacter pylori reinfection rate 3 years after successful eradication.

J Gastroenterol Hepatol. 2005 Mar;20(3):401

14.Massarrat S

.Marshall and Warren: the Nobel Prize winners in medicine in 2005

Arch Iran Med. 2006 Apr;9(2):177-80. No abstract available

15.  Mohammadi M, Doroud D, Mohajerani N, Massarrat S

 Helicobacter pylori antibiotic resistance in Iran.

World J Gastroenterol. 2005 Oct 14;11(38):6009-13

16.Fakheri H, Merat S, Hosseini V, Malekzadeh R

Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.

Aliment Pharmacol Ther. 2004 Jan 1;19(1):89-93

17. Malekzadeh R, Merat S, Abedi B, Babaei M, Arshi S, Majidpour A

Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population.

J Gastroenterol Hepatol. 2003 Jan;18(1):13-7

18.Roghani HS, Massarrat S, Shirekhoda M, Butorab Z 

Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori.

 J Gastroenterol Hepatol. 2003 Jul;18(7):778-82

19.Mohammadi M, Oghalaie A, Mohajerani N, Massarrat S, Nasiri M, Bennedsen M, Colding H, Andersen LP

Prevalence of Helicobacter pylori vacuolating cytotoxin and its allelic mosaicism as a predictive marker for Iranian dyspeptic patients.

Bull Soc Pathol Exot. 2003 Mar;96(1):3-5

20. Mohammadi M, Doroud D, Massarrat S, Farahvash

Clarithromycin resistance in Iranian H pylori strains before introduction of clarithromycin.

 Helicobacter. 2003 Feb;8(1):80

21.Alizadeh-Naeeni M, Saberi-Firoozi M, Pourkhajeh A, Taheri H, Malekzadeh R, Derakhshan MH, Massarrat S

Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study.

Digestion. 2002;66(2):92-8

22. Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, Massarrat S

Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.

Eur J Gastroenterol Hepatol. 2001 Aug;13(8):915-9

23. Fakheri H, Malekzadeh R, Merat S, Khatibian M, Fazel A, Alizadeh BZ, Massarrat S

Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.

Aliment Pharmacol Ther. 2001 Mar;15(3):411-6

24. Sotoudehmanesh R, Malekzadeh R, Vahedi H, Dariani NE, Asgari AA, Massarrat S

Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.

Digestion. 2001;64(4):222-5

25. Sotudehmanesh R, Malekzadeh R, Fazel A, Massarrat S, Ziad-Alizadeh B, Eshraghian MR

A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
 
J Gastroenterol Hepatol. 2001 Mar;16(3):264-8

26 Malekzadeh R, Ansari R, Vahedi H, Siavoshi F, Alizadeh BZ, Eshraghian MR, Vakili A, Saghari M, Massarrat S

Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease.

Aliment Pharmacol Ther. 2000 Mar;14(3):299-303

27. Kashifard M, Malekzadeh R, Siavoshi F, Mikaeli J, Massarrat S

Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin.

Eur J Gastroenterol Hepatol. 1998 Oct;10(10):847-50